Literature DB >> 22064655

Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells.

Wen-Chin Huang1, Xiangyan Li, Jian Liu, Jentai Lin, Leland W K Chung.   

Abstract

We previously reported that sterol regulatory element-binding protein-1 (SREBP-1) is involved in the transcriptional regulation of androgen receptor (AR) and formation of fatty acid through altered expression of fatty acid synthase (FASN). In this article, we provide a new finding that SREBP-1 induced oxidative stress in prostate cancer cells through increased production of reactive oxygen species (ROS) and expression of NADPH oxidase 5 (Nox5). We have shown that (i) expression of SREBP-1 protein is positively associated with the clinical Gleason grades in human prostate cancer; (ii) genetic overexpression or knockdown of SREBP-1 in prostate cancer cells resulted in corresponding increased or decreased AR, FASN and Nox5 expression, fatty acid and lipid droplet accumulation, and ROS generation; and (iii) SREBP-1 induces and promotes the growth, migration, invasion, and castration-resistant progression of prostate cancer cells in vitro and in vivo. Our data show a novel molecular mechanism by which SREBP-1 promotes prostate cancer growth and progression through alterations in the concerted intracellular metabolic and signaling networks involving AR, lipogenesis, and ROS in prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22064655      PMCID: PMC3262123          DOI: 10.1158/1541-7786.MCR-11-0206

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  48 in total

Review 1.  Statins and prostate cancer prevention: where we are now, and future directions.

Authors:  Teemu J Murtola; Tapio Visakorpi; Jorma Lahtela; Heimo Syvälä; Teuvo Lj Tammela
Journal:  Nat Clin Pract Urol       Date:  2008-06-10

2.  Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis.

Authors:  Takeo Nomura; Wen-Chin Huang; Haiyen E Zhau; Daqing Wu; Zhihui Xie; Hiromitsu Mimata; Majd Zayzafoon; Andrew N Young; Fray F Marshall; M Neale Weitzmann; Leland W K Chung
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

3.  Ezetimibe is an inhibitor of tumor angiogenesis.

Authors:  Keith R Solomon; Kristine Pelton; Kelly Boucher; Jinsoo Joo; Christopher Tully; David Zurakowski; Carl P Schaffner; Jayoung Kim; Michael R Freeman
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

4.  Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells.

Authors:  Wen-Chin Huang; Jonathan J Havel; Haiyen E Zhau; Wei Ping Qian; Hui-Wen Lue; Chia-Yi Chu; Takeo Nomura; Leland W K Chung
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

5.  Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.

Authors:  Binod Kumar; Sweaty Koul; Lakshmipathi Khandrika; Randall B Meacham; Hari K Koul
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

Review 6.  Mechanisms of ROS modulated cell survival during carcinogenesis.

Authors:  J S Clerkin; R Naughton; C Quiney; T G Cotter
Journal:  Cancer Lett       Date:  2008-03-26       Impact factor: 8.679

7.  Saturated fat intake predicts biochemical failure after prostatectomy.

Authors:  Sara S Strom; Yuko Yamamura; Michele R Forman; Curtis A Pettaway; Stephanie L Barrera; John DiGiovanni
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

8.  Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains.

Authors:  Bekir Cinar; Nishit K Mukhopadhyay; Gaoyuan Meng; Michael R Freeman
Journal:  J Biol Chem       Date:  2007-07-16       Impact factor: 5.157

9.  Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma.

Authors:  Taro Yamashita; Masao Honda; Hajime Takatori; Ryuhei Nishino; Hiroshi Minato; Hiroyuki Takamura; Tetsuo Ohta; Shuichi Kaneko
Journal:  J Hepatol       Date:  2008-10-12       Impact factor: 25.083

Review 10.  Cholesterol and cholesterol-rich membranes in prostate cancer: an update.

Authors:  Dolores Di Vizio; Keith R Solomon; Michael R Freeman
Journal:  Tumori       Date:  2008 Sep-Oct
View more
  95 in total

Review 1.  Metabolomic profiling of hormone-dependent cancers: a bird's eye view.

Authors:  Stacy M Lloyd; James Arnold; Arun Sreekumar
Journal:  Trends Endocrinol Metab       Date:  2015-08-01       Impact factor: 12.015

Review 2.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 3.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

Review 4.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

Review 5.  Molecular pathways: sterols and receptor signaling in cancer.

Authors:  Linara Gabitova; Andrey Gorin; Igor Astsaturov
Journal:  Clin Cancer Res       Date:  2013-10-24       Impact factor: 12.531

6.  RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression.

Authors:  Yongquan Wang; Jianghua Wang; Li Zhang; Omer Faruk Karatas; Longjiang Shao; Yiqun Zhang; Patricia Castro; Chad J Creighton; Michael Ittmann
Journal:  Cancer Res       Date:  2017-06-13       Impact factor: 12.701

7.  Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Authors:  Alejandro Schcolnik-Cabrera; Alma Chávez-Blanco; Guadalupe Domínguez-Gómez; Alfonso Dueñas-González
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

8.  MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer.

Authors:  Li Zhang; Jianghua Wang; Yongquan Wang; Yiqun Zhang; Patricia Castro; Longjiang Shao; Arun Sreekumar; Nagireddy Putluri; Nilanjan Guha; Saligrama Deepak; Arunkumar Padmanaban; Chad J Creighton; Michael Ittmann
Journal:  Cancer Res       Date:  2016-08-30       Impact factor: 12.701

Review 9.  The interplay between cell signalling and the mevalonate pathway in cancer.

Authors:  Peter J Mullen; Rosemary Yu; Joseph Longo; Michael C Archer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2016-08-26       Impact factor: 60.716

Review 10.  The emerging role of obesity, diet and lipid metabolism in prostate cancer.

Authors:  Matteo Ferro; Daniela Terracciano; Carlo Buonerba; Giuseppe Lucarelli; Danilo Bottero; Sisto Perdonà; Riccardo Autorino; Alessandro Serino; Francesco Cantiello; Rocco Damiano; Iulia Andras; Sabino De Placido; Giuseppe Di Lorenzo; Michele Battaglia; Barbara A Jereczek-Fossa; Vincenzo Mirone; Ottavio De Cobelli
Journal:  Future Oncol       Date:  2016-09-14       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.